OpenPV Signal Explorer
FAERS disproportionality dashboard
Reaction

Lupus Nephritis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,814 reports · 43 co-occurring drugs

As of the last recalculation, Lupus Nephritis appears in 1,814 FAERS reports alongside 43 co-occurring drug terms. The strongest observed disproportionality signal is BELIMUMAB (PRR 191.1).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Belimumab409191.1193.6
Voclosporin5777.778.2
Hydroxychloroquine32460.460.7
Mycophenolate Mofetil Hydrochloride49356.756.9
Mycophenolate Mofetil49156.556.7
Mycophenolic Acid12447.647.8
Mycophenilic Acid8247.547.7
Indapamide6643.844.0
Azathioprine22032.532.5
Calcitriol Capsules 0.25 Mcg5130.030.1
Calcitriol Capsules 0.5 Mcg5130.030.1
Calcitriol5129.729.7
Colchicine5625.125.2
Daspone2023.823.9
Dapsone Gel, 5%2023.823.9
Dapsone2021.721.8
Hydroxychloroquine Sulfate15721.621.6
Obinutuzumab3021.321.3
Methylprednisolone22421.121.1
Prednisolone26919.919.9
Prednisolone Oral26919.919.9
Prednisolone Oral Solution26919.919.9
Rituximab27517.417.4
Diphenhydramine Hydrochloride Capsule, Liquid Filled3116.916.9
Tacrolimus19415.815.8
Cyclophosphamide Injection, Solution21115.315.4
Cyclophosphamide21115.315.4
Cyclophosphamide For Injection21115.315.4
Tacrolimus Ointment 0.1%15215.215.2
Tacrolimus Extended-Release Capsules15215.215.2
Methylprednisolone Sodium Succinate5814.814.8
Irbesartan4712.412.4
Apixaban6611.711.7
Diphenhydramine6111.411.4
Darbepoetin Alfa5211.411.4
Leucovorin Calcium1810.910.9
Cyclosporine818.78.7
Leflunomide768.78.7
Dapagliflozin238.58.5
Olanzapine677.47.4
Eculizumab234.94.9
Emicizumab43.73.7
Sofosbuvir63.53.5

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.